
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1183 | 1183 | 1107 | 658 | 658 | - |
Fund Return | 18.32% | 18.32% | 10.7% | -13.03% | -8.04% | - |
Place in category | 12 | 12 | 28 | 52 | 37 | - |
% in Category | 13 | 13 | 32 | 96 | 100 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIFM China Emerging Power Class A | 5.34B | 5.66 | -5.79 | 7.93 | ||
CIFM China Emerging Power Class H | 5.34B | 5.66 | -5.82 | - | ||
CIFM Technology Qian Yan Alloc | 2.67B | 2.65 | -6.55 | - | ||
China Intl AsiaPacific Advantage St | 2.43B | 2.62 | 2.96 | 4.96 | ||
China International China Advanced | 1.69B | 6.76 | -4.77 | 4.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 2.42B | -9.27 | 14.47 | - | ||
E Fund Global Medical Industry CNY | 938.4M | 19.91 | 2.10 | - | ||
CIFM Global Duoyuan QDII CNH | 704.19M | -2.06 | 6.29 | - | ||
006308 | 672.47M | -3.17 | 7.38 | - | ||
006309 | 672.47M | -3.41 | 6.32 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BeiGene Ltd Ordinary Shares | - | 8.07 | - | - | |
Innovent Biologics | KYG4818G1010 | 7.51 | 47.75 | +9.27% | |
Jiangsu Hengrui | CNE0000014W7 | 7.05 | 48.38 | -0.25% | |
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 6.37 | 87.45 | +1.97% | |
Sichuan Kelun Biotech | CNE1000062J1 | 4.97 | 302.00 | +7.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Strong Sell | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review